HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mollet, L. Articles by Autran, B. Search for Related Content PubMed PubMed Citation Articles by Mollet, L. Articles by Autran, B.

Dynamics of HIV-Specific CD8⁺ T Lymphocytes with Changes in Viral Load¹

Lucile Mollet^*, Tai-Sheng Li^*, Assia Samri^*, Claire Tournay, Roland Tubiana, Vincent Calvez^§, Patrice Debré^*, Christine Katlama, Brigitte Autran^2,* and the RESTIM and COMET Study Groups

^* Laboratoire d’Immunologie Cellulaire et Tissulaire, Bâtiment Centre d’Etudes et de Recherches en Virologie et Immunologie, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7627, Paris, France; Immunotech-Coulter-Beckman, Marseille, France; and Département des Maladies Infectieuses and ^§ Département de Virologie, Hôpital Pitié-Salpétriêre, Paris, France

The influence of HIV burden variations on the frequencies of Ag-specific CD8⁺ T cell responses was evaluated before and during highly active antiretroviral therapy by analyzing the number, diversity, and function of these cells. The frequencies of HLA-A2-restricted CD8⁺ PBL binding HLA-A2/HIV-epitope tetramers or producing IFN- were below 1%. A panel of 16 CTL epitopes covering 15 HLA class I molecules in 14 patients allowed us to test 3.8 epitopes/patient and to detect 2.2 ± 1.8 HIV epitope-specific CD8⁺ subsets per patient with a median frequency of 0.24% (0.11–4.79%). During the first month of treatment, viral load rapidly decreased and frequencies of HIV-specific CD8 PBL tripled, eight new HIV specificities appeared of 11 undetectable at entry, while CMV-specific CD8⁺ PBL also appeared. With efficient HIV load control, all HIV specificities decayed involving a reduction of the CD8⁺CD27⁺CD11a^high HIV-specific effector subset. Virus rebounds triggered by scheduled drug interruptions or transient therapeutic failures induced four patterns of epitope-specific CD8⁺ lymphocyte dynamics, i.e., peaks or disappearance of preexisting specificities, emergence of new specificities, or lack of changes. The HIV load rebounds mobilized both effector/memory HIV- and CMV-specific CD8⁺ lymphocytes. Therefore, frequencies of virus-specific CD8 T cells appear to be positively correlated to HIV production in most cases during highly active antiretroviral therapy, but an inverse correlation can also be observed with rapid virus changes that might involve redistribution, sequestration, or expansion of these Ag-specific CD8 T cells. Future strategies of therapeutic interruptions should take into account these various HIV-specific cell dynamics during HIV rebounds.

This article has been cited by other articles:

				Y. M. Mueller, C. Petrovas, D. H. Do, S. R. Altork, T. Fischer-Smith, J. Rappaport, J. D. Altman, M. G. Lewis, and P. D. Katsikis Early Establishment and Antigen Dependence of Simian Immunodeficiency Virus-Specific CD8+ T-Cell Defects J. Virol., October 15, 2007; 81(20): 10861 - 10868. [Abstract] [Full Text] [PDF]

				M. Lambert, M. Gannage, A. Karras, M. Abel, C. Legendre, D. Kerob, F. Agbalika, P.-M. Girard, C. Lebbe, and S. Caillat-Zucman Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma Blood, December 1, 2006; 108(12): 3871 - 3880. [Abstract] [Full Text] [PDF]

				D. Meyer-Olson, K. W. Brady, M. T. Bartman, K. M. O'Sullivan, B. C. Simons, J. A. Conrad, C. B. Duncan, S. Lorey, A. Siddique, R. Draenert, et al. Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire Blood, March 15, 2006; 107(6): 2373 - 2383. [Abstract] [Full Text] [PDF]

				B. L. Lohman, J. A. Slyker, B. A. Richardson, C. Farquhar, J. M. Mabuka, C. Crudder, T. Dong, E. Obimbo, D. Mbori-Ngacha, J. Overbaugh, et al. Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants J. Virol., July 1, 2005; 79(13): 8121 - 8130. [Abstract] [Full Text] [PDF]

				F. J. Ibarrondo, P. A. Anton, M. Fuerst, H. L. Ng, J. T. Wong, J. Matud, J. Elliott, R. Shih, M. A. Hausner, C. Price, et al. Parallel Human Immunodeficiency Virus Type 1-Specific CD8+ T-Lymphocyte Responses in Blood and Mucosa during Chronic Infection J. Virol., April 1, 2005; 79(7): 4289 - 4297. [Abstract] [Full Text] [PDF]

				S. Cardinaud, A. Moris, M. Fevrier, P.-S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel Identification of Cryptic MHC I-restricted Epitopes Encoded by HIV-1 Alternative Reading Frames J. Exp. Med., April 19, 2004; 199(8): 1053 - 1063. [Abstract] [Full Text] [PDF]

				V. Novitsky, P. Gilbert, T. Peter, M. F. McLane, S. Gaolekwe, N. Rybak, I. Thior, T. Ndung'u, R. Marlink, T. H. Lee, et al. Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection J. Virol., December 20, 2002; 77(2): 882 - 890. [Abstract] [Full Text] [PDF]

				D. H. Margolin, E. F. Helmuth Saunders, B. Bronfin, N. de Rosa, M. K. Axthelm, X. Alvarez, and N. L. Letvin High Frequency of Virus-Specific B Lymphocytes in Germinal Centers of Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys J. Virol., March 19, 2002; 76(8): 3965 - 3973. [Abstract] [Full Text] [PDF]

				S. D. W. Frost, J. Martinez-Picado, L. Ruiz, B. Clotet, and A. J. Leigh Brown Viral Dynamics during Structured Treatment Interruptions of Chronic Human Immunodeficiency Virus Type 1 Infection J. Virol., February 1, 2002; 76(3): 968 - 979. [Abstract] [Full Text] [PDF]

				G. M. Ortiz, J. Hu, J. A. Goldwitz, R. Chandwani, M. Larsson, N. Bhardwaj, S. Bonhoeffer, B. Ramratnam, L. Zhang, M. M. Markowitz, et al. Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses in Subjects Treated Early after Infection J. Virol., January 1, 2002; 76(1): 411 - 415. [Abstract] [Full Text] [PDF]

				G. M. Ortiz, M. Wellons, J. Brancato, H. T. T. Vo, R. L. Zinn, D. E. Clarkson, K. Van Loon, S. Bonhoeffer, G. D. Miralles, D. Montefiori, et al. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects PNAS, October 25, 2001; (2001) 221452198. [Abstract] [Full Text] [PDF]

				J. P. Casazza, M. R. Betts, L. J. Picker, and R. A. Koup Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+ T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy J. Virol., July 15, 2001; 75(14): 6508 - 6516. [Abstract] [Full Text]

				G. M. Ortiz, M. Wellons, J. Brancato, H. T. T. Vo, R. L. Zinn, D. E. Clarkson, K. Van Loon, S. Bonhoeffer, G. D. Miralles, D. Montefiori, et al. Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects PNAS, November 6, 2001; 98(23): 13288 - 13293. [Abstract] [Full Text] [PDF]